The press releases on this website are provided for historical reference purposes only.
Please note that certain information may have changed since the date of release.
Tokyo, Japan - Sony Corporation announced that has launched a platform for the sharing of medical and health information that leverages the FeliCa contactless IC card technology and utilizes secure* cloud systems, placing the highest priority on the protection of users' personal information. Sony has established this platform in a relatively short period of time, and with it, participating facilities will benefit from easy sharing of users' health data.
The FeliCa contactless IC card technology has a strong track record in realms such as transportation and e-money. Utilizing FeliCa technology, users of this new platform will be able to display and record data simply by tapping their cards against readers at participating locations. The secure cloud system that this platform utilizes is underpinned by Sony's unique, patented data separation technology, which has been recognized for its innovativeness and applicability.
As the first service to be offered on its new platform, Sony launched the "harmo" electronic medication notebook in July 2016.
Since the autumn of 2011, Sony has deployed harmo to select markets on a trial run basis. Through these trials for the harmo electronic medication notebook, Sony has worked to confirm the real world functional value of a platform for the sharing of medical and health information.
The practical usefulness of harmo has been recognized, through this trial run, by a wide range of facilities, from pharmacies and hospitals to medical and dental clinics. As of July 2016, harmo has been adopted by approximately 880 different medical care facilities and pharmacies in 10 cities across Japan. All told, more than 75,000 people are using harmo at these locations in their daily lives.
harmo is an electronic medication notebook accessed through the harmo card, one of which is provided to every user. A card can be created for anyone, from toddlers to the elderly, with no smartphone required. The user can share his or her prescription information with doctors or pharmacists simply by tapping the card against a reader. By opting for a card-based system, Sony hopes to increase the number of harmo users. Because reliable data is recorded to harmo, it makes it easier for patients to obtain the most appropriate medication guidance from pharmacists.
A dedicated harmo smartphone app offers additional benefits to users. With the app, they can set alarms to remind themselves to take their medicine, manage their prescription history, declare their preference for generic medications, and record known allergies. The harmo app also makes it easier to provide support to those closest and dearest to users. Guardians can manage the prescription information of their children, and families can check up on their elderly relatives from whom they live apart. In these ways, harmo is expected to contribute to improved "medication adherence," a term that refers to patients taking their medications as prescribed.
The future proliferation of harmo will help to reduce incidents where patients forget to take their medication, as well as increase the effectiveness of pharmacists' medication guidance. These are likely to contribute to fewer leftover drugs and duplicate prescriptions, thereby reducing unnecessary health care costs.
Sony will build upon the knowledge and relationships that it gained through the approximately 5-year trial run for harmo, and it will continue to promote this platform for the sharing of community-based medical and health information to medical care facilities and pharmacies, primarily on the strength of the harmo service. Sony will also work to discover new value in harmo, such as by examining the ways in which the statistics accumulated by the service can be leveraged to provide users with additional meaningful information. In the longer-term, Sony will continue to develop the platform with the aim of adapting it to a wide range of different fields.
|Facility type||Service participation fee|
|Pharmacy||Available on the harmo website:
Introduction - harmo website
|Hospital, clinic||To be announced soon on the harmo website (Service slated to launch on December 1, 2016)|
|Sapporo City, Hokkaido Prefecture; Saitama Prefecture; Tokyo Metropolis; Kanagawa Prefecture; Shiga Prefecture; Osaka Prefecture; Hyogo Prefecture|
Sony will work to expand service availability, area by area. Please access the harmo website for the latest details pertaining to availability.
For inquiries from facilities considering becoming a participating harmo location:
Contact - harmo website